Pearl Therapeutics
Morristown · Founded 2006
About Pearl Therapeutics
Pearl Therapeutics is developing unique dual and triple combination products for the treatment of widely prevalent respiratory diseases, including chronic obstructive pulmonary disease. Pearl's current focus is on making advanced inhaled therapies available to broad patient populations via familiar and accepted metered dose inhalers. Pearl is a privately held company led by a seasoned team of respiratory product development experts. Pearl aims to offer patients and healthcare providers alternatives that better meet their needs and improve upon the safety and efficacy of existing respiratory therapeutics to achieve better clinical outcomes.
Company Facts
- Founded: 2006
- Legal name: Pearl Therapeutics, Inc.
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $100K – $500K
- Total funding: $255.5M
- Funding stage: M&A
- Last round: Series Unknown (Apr 2013)
- Website: pearltherapeutics.com
- Phone: 650-305-2600
Social Profiles
Canonical: https://fsome.com/organization/pearl-therapeutics-8448433 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.